GlassScriptPhysician profile
Paul C Laffay
NPI 1447469697
$1,413.44
in general payments reported to CMS, 2019-2025
19 companies · $61.10 in 2025
The $61.10 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.29 · 2020: $704 · 2021: $82.47 · 2022: $77.73 · 2023: $290 · 2024: $129 · 2025: $61.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $479.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $674.28 | 2020 | |
| Ethicon US, LLC | $179.47 | 2019-2024 | Echelon Flex, Echelon Circular |
| Sirius Medical Systems | $113.02 | 2023-2024 | Pintuition |
| Teleflex LLC | $92.98 | 2023 | Instruments: General |
| Abbvie INC. | $50.08 | 2021-2023 | |
| Karl Storz Endoscopy-America | $46.39 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $42.76 | 2024-2025 | |
| Integra Lifesciences Corporation | $41.68 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Merck Sharp & Dohme LLC | $27.12 | 2020-2023 | Lynparza, Keytruda |
| Kci USA, INC. | $16.89 | 2023 | V.A.C.Ulta, V.A.C. Veraflo, Prevena |
| Pacira Pharmaceuticals Incorporated | $16.19 | 2021 | |
| Heron Therapeutics, INC. | $15.99 | 2024 | Zynrelef |
| Elucent Medical | $15.85 | 2023 | |
| Dilon Technologies, INC. | $15.06 | 2023 | Hemoblast Bellows |
| Hologic INC | $14.84 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $14.41 | 2022 | |
| Convatec INC. | $13.34 | 2022 | |
| Medline Industries LP | $12.04 | 2021 | |
| Davol INC. | $11.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Laffay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.